Childhood skin diseases are associated with severe burden on patients, families, and health care providers. Despite this burden, effective treatments remain sparse and the pace of research slow. To help overcome these challenges, the Pediatric Dermatology Research Alliance (PeDRA) is committed to supporting an annual competitive research grants program.
As part of this program, this year PeDRA is offering PeDRA Research Grants to support early-stage research projects where preliminary data may be lacking, and to establish infrastructure and foster collaborations that support larger-scale studies in future. Applications may be submitted by either a single investigator or multiple investigators at multiple institutions to receive:
$40,000 to be used over two years to support larger scale projects.
$20,000 to be used over either one or two years to support more modestly sized projects requiring less financial support.
Up to $20,000 to be used over one year to support smaller scale pilot projects.
PeDRA Research Grants are driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease. They are intended to provide financial support for early-stage studies that are unlikely to be funded elsewhere, and to provide a mentorship opportunity for both grant preparation and project execution. Ultimately, PeDRA Research Grants are expected to generate data, establish research infrastructure, and foster collaborations that form the basis for larger scale studies with a high impact on patient lives.
- May be submitted by individuals or teams.
- Applications due Thursday, September 29, 2022.
- Optional opportunity to submit a preliminary application by August 15, 2022 to be eligible to receive preliminary reviewer comments and discuss their applications with a representative from the PeDRA Grants Committee.
Last Year’s Research Grant Recipients:
Anna Garza-Mayers, MD, PhD
University of Massachusetts Chan Medical School
Assessment of hearing and vision in pediatric vitiligo patients
Sonal Shah, MD
Case Western Reserve University
Needle-free delivery of intralesional triamcinolone for pediatric alopecia areata: a pilot study of patient tolerability
Naiem Issa, MD, PhD
University of Miami Leonard M. Miller School of Medicine
Pharmacologic Characterization of NTI-001 as First-In-Class Gαq R183Q Mutant Small Molecule Inhibitor
JiaDe Yu, MD
Massachusetts General Hospital
Evaluation of the Efficacy of Popular Over the Counter Ointments in Atopic Dermatitis: A Double Blinded Randomized Controlled Trial